Jones Financial Companies Lllp boosted its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 43.2% during the 4th ...

DexCom (NASDAQ:DXCM – Get Free Report) had its price target increased by equities researchers at Citigroup from $101.00 to ...

It offers various medical devices and products, including Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time ... third-party gadgets and apps that help combat diabetes.

Adjusted earnings are expected to come in at $0.50 per share. DexCom Total Revenue Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they ...

DexCom specializes in continuous glucose monitoring systems, primarily focusing on individuals managing diabetes. Its innovative CGM systems, like the G6 and the newer G7, offer real-time glucose ...